The GBCF is a 501(c)(3) public charity that provides resources and support to patients & caregivers, and raises funds for gallbladder cancer research.
Joined December 2024
- Tweets24
- Following2
- Followers43
- Likes0
Less than 1% of all cancer diagnoses are gallbladder cancer.
Rare shouldn't mean underfunded, under-researched, or overlooked. This #RareCancerDay, we’re pushing for more clinical trials and federal research dollars.
Stand with us: gallbladdercancer.org/ #GallbladderCancer #GBC
This #RareDiseaseDay, the Gallbladder Cancer Foundation is joining the global community to demand #HealthEquity. The fight against rare cancers involves fewer treatment options, complex diagnostic journeys, and a critical need for research funding. Stand with us today.
Big news for Rare Disease Week! 📢 The Gallbladder Cancer Foundation has partnered with Citizen Health to launch the AI Advocate for Gallbladder Cancer: citizen.health/ai-advocate/g…
Today we wear our ribbons, share our stories, and raise our voices. 🎗️
World Cancer Day is a reminder that prevention, detection, and community save lives. Whether you’re a survivor, a fighter, or a supporter—we see you, and we stand with you.
Big news! 📣 The Gallbladder Cancer Foundation is now an official member of @NORD_Rare!
We’re joining forces to amplify the voices of #GallbladderCancer patients and fight for better research, advocacy, and care. Together, we are rare but never alone. 🎗️🤝
#RareDisease #GBC
Today is Rare Cancer Day, which highlights the significance of rare cancers, including gallbladder cancer. Collectively, rare cancers make up 20% of all diagnosed cancer cases.
As part of Rare Cancer Day, our Founder, Sanjeev Kumar, had the privilege of participating in a panel discussion with Dr. Haley Ellis and Jim Palma, the CEO of the TargetCancer Foundation for National Organization for Rare Disorders (NORD's) Rare Cancer Day webinar.
The webinar focused on the significance of biomarker testing in the treatment of rare cancers. The webinar can be accessed at the following link: youtube.com/watch?v=2RDGDouF…
The NCCN Patient Guidelines for Gallbladder and Bile Duct Cancers have undergone a recent revision. We are pleased to announce that the Gallbladder Cancer Foundation has been incorporated as a resource for patients within the guidelines.
Furthermore, the NCCN has recently translated the Gallbladder and Bile Duct Cancer patient guidelines into Spanish.
The resource is available on the NCCN website at the following link: nccn.org/patientresources/pa…
NORD will have a free webinar on September 25th titled: "Biomarker Testing in Rare Cancers: From Barriers to Breakthroughs," brought to you by NORD and the NORD Rare Cancer Coalition.
Register today to learn more! bit.ly/3VKCr0j
It’s here: the Collective Action Roadmap for GI Cancers, a new resource co-created by patient advocacy groups, including the Gallbladder Cancer Foundation, to drive progress across the full GI cancer care journey. Explore the roadmap at: gicancersalliance.org/roadma…
We're excited to announce that the Gallbladder Cancer Foundation was selected as one of the winners of the Daiichi Sankyo Community Advocacy Innovation Award (CAIA) Grant and was awarded $40,000 to support our Gallbladder Cancer Patient Registry Initiative launching in July 2025.
